Myeloma Paper of the Day, July 12th, Suggested by Robert Orlowski – OncoDaily
Myeloma Paper of the Day, July 12th, Suggested by Robert Orlowski / Allan Motyer, Amanda Light, cancer, Casey J.A. Anttila, Daniela Amann-Zalcenstein, Edwin D
Related Articles
Sequential BCMA CAR-T Cell Therapy in Refractory Multiple Myeloma – PubMed
Multiple myeloma (MM) relapsing after BCMA-directed chimeric antigen receptor T-cell (CAR-T) treatment remains a therapeutic challenge. Data on re-exposure to CAR-T targeting the same antigen…
Petros Grivas is Receiving 2025 Young Investigator Award – OncoDaily
Petros Grivas is Receiving 2025 Young Investigator Award / ASCO, cancer, Chandler Park, ECOG-ACRIN Cancer Research Group, Fred Hutch Cancer Center, OncoDaily,
Profiling the spatial architecture of multiple myeloma in human bone marrow trephine biopsy specimens with spatial transcriptomics – PubMed
The bone marrow microenvironment is intimately linked to the biology that underpins the development and progression of multiple myeloma. However, the complex cellular and molecular…
Pashtoon Kasi: The 1st Agnostic Study of a PARP Inhibitor – OncoDaily
Pashtoon Kasi: The 1st Agnostic Study of a PARP Inhibitor / (JCOPO), Alexa B. Schrock, ASCO, Brennan Decker, cancer, Doug E. Laux, E. Gabriela Chiorean,…
Boosting CAR T-Cell Efficacy by Blocking Proteasomal Degradation of Membrane Antigens – PubMed
Chimeric antigen receptor (CAR) T cells exhibit high response rates in B cell malignancies, but most patients eventually relapse. A key mechanism of treatment failure…
Rahul Banerjee: Largest RW Experience with Teclistamab – OncoDaily
Rahul Banerjee: Largest RW Experience with Teclistamab / Adam S. Sperling, Adriana Rossi, Aimaz Afrough, Alex Lieberman-Cribbin, Alfred L. Garfall, Andre de
Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy Consortium – PubMed
Teclistamab is an anti-CD3xBCMA bispecific antibody approved for use in relapsed/refractory multiple myeloma (MM). We undertook a retrospective study of post-approval, real-world outcomes with teclistamab…
Jenna Dean: The first World Radiotherapy Awareness Day will be held on September 7 – OncoDaily
Jenna Dean: The first World Radiotherapy Awareness Day will be held on September 7 / cancer, Jenna Dean, OncoDaily, Oncology, World Radiotherapy Awareness
